|
US633031A
(en)
*
|
1898-05-02 |
1899-09-12 |
Gas Motoren Fabrik Deutz |
Process of making gas.
|
|
US4179337A
(en)
*
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US4703008A
(en)
*
|
1983-12-13 |
1987-10-27 |
Kiren-Amgen, Inc. |
DNA sequences encoding erythropoietin
|
|
NZ210501A
(en)
*
|
1983-12-13 |
1991-08-27 |
Kirin Amgen Inc |
Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
|
|
KR850004274A
(ko)
*
|
1983-12-13 |
1985-07-11 |
원본미기재 |
에리트로포이에틴의 제조방법
|
|
US4677195A
(en)
*
|
1985-01-11 |
1987-06-30 |
Genetics Institute, Inc. |
Method for the purification of erythropoietin and erythropoietin compositions
|
|
EP0545913B1
(en)
*
|
1986-08-18 |
1999-02-24 |
Emisphere Technologies, Inc. |
Delivery systems for pharmacological agents
|
|
US5080891A
(en)
*
|
1987-08-03 |
1992-01-14 |
Ddi Pharmaceuticals, Inc. |
Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
|
|
US5006333A
(en)
*
|
1987-08-03 |
1991-04-09 |
Ddi Pharmaceuticals, Inc. |
Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
|
|
WO1990008822A1
(en)
*
|
1989-02-03 |
1990-08-09 |
Genetics Institute, Inc. |
Erythropoietin receptor
|
|
US5143854A
(en)
*
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
|
US5424186A
(en)
*
|
1989-06-07 |
1995-06-13 |
Affymax Technologies N.V. |
Very large scale immobilized polymer synthesis
|
|
US5013556A
(en)
*
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5723286A
(en)
*
|
1990-06-20 |
1998-03-03 |
Affymax Technologies N.V. |
Peptide library and screening systems
|
|
US5292654A
(en)
*
|
1990-12-13 |
1994-03-08 |
Whitehead Institute For Biomedical Research |
Mutant EPO receptor and uses therefor
|
|
AU643141B2
(en)
*
|
1991-03-15 |
1993-11-04 |
Amgen, Inc. |
Pulmonary administration of granulocyte colony stimulating factor
|
|
JP2001524926A
(ja)
*
|
1991-09-18 |
2001-12-04 |
アフィマックス テクノロジーズ ナームロゼ フェンノートシャップ |
オリゴマーの雑多ライブラリーの集合体を合成する方法
|
|
US5614184A
(en)
*
|
1992-07-28 |
1997-03-25 |
New England Deaconess Hospital |
Recombinant human erythropoietin mutants and therapeutic methods employing them
|
|
US6153407A
(en)
*
|
1992-07-28 |
2000-11-28 |
Beth Israel Deaconess Medical Center |
Erythropoietin DNA having modified 5' and 3' sequences and its use to prepare EPO therapeutics
|
|
US5919455A
(en)
*
|
1993-10-27 |
1999-07-06 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US5830851A
(en)
*
|
1993-11-19 |
1998-11-03 |
Affymax Technologies N.V. |
Methods of administering peptides that bind to the erythropoietin receptor
|
|
US5773569A
(en)
*
|
1993-11-19 |
1998-06-30 |
Affymax Technologies N.V. |
Compounds and peptides that bind to the erythropoietin receptor
|
|
US5919758A
(en)
*
|
1994-03-22 |
1999-07-06 |
Beth Israel Deaconess Medical Center |
Modified polypeptides with altered biological activity
|
|
US5747446A
(en)
*
|
1994-03-22 |
1998-05-05 |
Beth Israel Deaconess Medical Center |
Modified polypeptides with increased biological activity
|
|
US5580853A
(en)
*
|
1994-03-22 |
1996-12-03 |
New England Deaconess Hospital |
Modified polypeptides with increased biological activity
|
|
US5451569A
(en)
*
|
1994-04-19 |
1995-09-19 |
Hong Kong University Of Science And Technology R & D Corporation Limited |
Pulmonary drug delivery system
|
|
CZ391097A3
(cs)
*
|
1995-06-07 |
1998-07-15 |
Ortho Pharmaceutical Corporation |
Látky a peptidy vážící se na erythropoietinový receptor
|
|
US6251864B1
(en)
*
|
1995-06-07 |
2001-06-26 |
Glaxo Group Limited |
Peptides and compounds that bind to a receptor
|
|
US5654276A
(en)
*
|
1995-06-07 |
1997-08-05 |
Affymax Technologies N.V. |
Peptides and compounds that bind to the IL-5 receptor
|
|
US5677280A
(en)
*
|
1995-06-07 |
1997-10-14 |
Glaxo Group Limited |
Peptides and compounds that bind to the IL-5 receptor
|
|
US5767078A
(en)
*
|
1995-06-07 |
1998-06-16 |
Johnson; Dana L. |
Agonist peptide dimers
|
|
US5668110A
(en)
*
|
1995-06-07 |
1997-09-16 |
Affymax Technologies N.V. |
Peptides and compounds that bind to the IL-5 receptor
|
|
TR199701526T1
(xx)
*
|
1995-06-07 |
1998-03-21 |
Glaxo Group Limited |
Bir trombopoietin resept�r�ne ba�lanan peptitler ve bile�ikler.
|
|
US5683983A
(en)
*
|
1995-06-07 |
1997-11-04 |
Glaxo Group Limited |
Peptides and compounds that bind to the IL-5 receptor
|
|
US5869451A
(en)
*
|
1995-06-07 |
1999-02-09 |
Glaxo Group Limited |
Peptides and compounds that bind to a receptor
|
|
US5672662A
(en)
*
|
1995-07-07 |
1997-09-30 |
Shearwater Polymers, Inc. |
Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
|
|
US6346390B1
(en)
*
|
1996-03-08 |
2002-02-12 |
Receptron, Inc. |
Receptor derived peptides involved in modulation of response to ligand binding
|
|
US6103879A
(en)
*
|
1996-06-21 |
2000-08-15 |
Axys Pharmaceuticals, Inc. |
Bivalent molecules that form an activating complex with an erythropoietin receptor
|
|
EP1731174A3
(en)
*
|
1996-08-02 |
2007-01-17 |
Ortho-McNeil Pharmaceutical, Inc. |
Polypeptides having a covalently bound N-terminal polyethylene glycol via hydrazone or oxime bond
|
|
US5932546A
(en)
*
|
1996-10-04 |
1999-08-03 |
Glaxo Wellcome Inc. |
Peptides and compounds that bind to the thrombopoietin receptor
|
|
US6221608B1
(en)
*
|
1997-01-22 |
2001-04-24 |
Ortho Pharmaceutical Corporation |
Methods for identifying erythropoietin receptor binding protein
|
|
US6074097A
(en)
*
|
1997-04-28 |
2000-06-13 |
Dai Nippon Printing Co., Ltd. |
Package, package manufacturing method and package manufacturing system for carrying out the package manufacturing method
|
|
JP4304757B2
(ja)
*
|
1998-04-24 |
2009-07-29 |
株式会社デンソー |
Ａｂｓアクチュエータ
|
|
ES2245114T3
(es)
*
|
1998-08-06 |
2005-12-16 |
Mountain View Pharmaceuticals, Inc. |
Conjugados de peg-oxidasa de urato y su uso.
|
|
US6783965B1
(en)
*
|
2000-02-10 |
2004-08-31 |
Mountain View Pharmaceuticals, Inc. |
Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
|
|
US6552167B1
(en)
*
|
1998-08-28 |
2003-04-22 |
Gryphon Therapeutics, Inc. |
Polyamide chains of precise length
|
|
US6660843B1
(en)
*
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
JP2002529502A
(ja)
*
|
1998-11-17 |
2002-09-10 |
スミスクライン・ビーチャム・コーポレイション |
血小板減少症の治療法
|
|
CZ299516B6
(cs)
*
|
1999-07-02 |
2008-08-20 |
F. Hoffmann-La Roche Ag |
Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
|
|
JO2291B1
(en)
*
|
1999-07-02 |
2005-09-12 |
اف . هوفمان لاروش ايه جي |
Erythropoietin derivatives
|
|
AUPQ873300A0
(en)
*
|
2000-07-12 |
2000-08-03 |
Medvet Science Pty. Ltd. |
A binding motif of a receptor (2)
|
|
ATE350044T1
(de)
*
|
1999-09-24 |
2007-01-15 |
Smithkline Beecham Corp |
Thrombopoietinmimetika
|
|
WO2001023556A1
(en)
*
|
1999-09-27 |
2001-04-05 |
Chugai Seiyaku Kabushiki Kaisha |
Novel hemopoietin receptor protein, nr12
|
|
US6703480B1
(en)
*
|
1999-11-24 |
2004-03-09 |
Palani Balu |
Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and use
|
|
US6858630B2
(en)
*
|
1999-12-06 |
2005-02-22 |
Smithkline Beecham Corporation |
Naphthimidazole derivatives and their use as thrombopoietin mimetics
|
|
JP2004512258A
(ja)
*
|
2000-03-21 |
2004-04-22 |
ウィスコンシン アルムニ リサーチ ファンデイション |
生物系における細胞応答の調節のための方法および試薬
|
|
US6777387B2
(en)
*
|
2000-03-31 |
2004-08-17 |
Enzon Pharmaceuticals, Inc. |
Terminally-branched polymeric linkers containing extension moieties and polymeric conjugates containing the same
|
|
PL219131B1
(pl)
*
|
2000-05-15 |
2015-03-31 |
Hoffmann La Roche |
Ciekła kompozycja farmaceutyczna, sposób jej wytwarzania oraz jej zastosowanie
|
|
EP1325324A4
(en)
*
|
2000-08-02 |
2004-11-10 |
Ortho Mcneil Pharm Inc |
IMPROVED ANTIVIRAL AND ANTI-CANCER CHEMOTHERAPY USING ERYTHROPOIETIN ADMINISTRATION (EPO)
|
|
EE200300089A
(et)
*
|
2000-09-08 |
2005-02-15 |
Gryphon Therapeutics, Inc. |
Sünteetilised erütropoeesi stimuleerivad valgud, nende valmistamismeetodid ning kasutamine
|
|
CA2431964C
(en)
*
|
2000-12-20 |
2013-09-10 |
F. Hoffmann-La Roche Ag |
Conjugates of erythropoietin (pep) with polyethylene glycol (peg)
|
|
US7767643B2
(en)
*
|
2000-12-29 |
2010-08-03 |
The Kenneth S. Warren Institute, Inc. |
Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
|
|
US6531121B2
(en)
*
|
2000-12-29 |
2003-03-11 |
The Kenneth S. Warren Institute, Inc. |
Protection and enhancement of erythropoietin-responsive cells, tissues and organs
|
|
FR2823220B1
(fr)
*
|
2001-04-04 |
2003-12-12 |
Genodyssee |
Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
|
|
US20020169128A1
(en)
*
|
2001-04-09 |
2002-11-14 |
Geroge Sigounas |
Erythropoietin ameliorates chemotherapy-induced toxicity in vivo
|
|
AU2002345938A1
(en)
*
|
2001-06-28 |
2003-03-03 |
Mountain View Pharmaceuticals, Inc. |
Polymer stabilized proteinases
|
|
US6784154B2
(en)
*
|
2001-11-01 |
2004-08-31 |
University Of Utah Research Foundation |
Method of use of erythropoietin to treat ischemic acute renal failure
|
|
US20050176627A1
(en)
*
|
2002-09-09 |
2005-08-11 |
Anthony Cerami |
Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin
|
|
US8129330B2
(en)
*
|
2002-09-30 |
2012-03-06 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
|
NZ541122A
(en)
*
|
2002-12-26 |
2008-09-26 |
Mountain View Pharmaceuticals |
Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity
|
|
EA008866B1
(ru)
*
|
2002-12-26 |
2007-08-31 |
Маунтин Вью Фамэсьютикэлс, Инк. |
ПОЛИМЕРНЫЙ КОНЪЮГАТ МОДИФИКАЦИЙ ИНТЕРФЕРОНА-β, ФАРМАЦЕВТИЧЕСКИЕ ПРОДУКТЫ НА ЕГО ОСНОВЕ И СПОСОБ ИХ ПОЛУЧЕНИЯ
|
|
JP4266028B2
(ja)
*
|
2003-05-12 |
2009-05-20 |
アフィーマックス・インコーポレイテッド |
エリスロポエチン受容体に結合する新規ペプチド
|